Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study

Título

Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study

Autor

Roberto de la Rica, Marcio Borges, Maria Aranda, Alberto del Castillo, Antonia Socias, Antoni Payeras, Gemma Rialp, Lorenzo Socias, Lluis Masmiquel, Marta Gonzalez-Freire

Descripción

There is limited information available describing the clinical and epidemiological features of Spanish patients requiring hospitalization for coronavirus disease 2019 (COVID-19). In this observational study, we aimed to describe the clinical characteristics and epidemiological features of severe (non-ICU) and critically patients (ICU) with COVID-19 at triage, prior to hospitalization. Forty-eight patients (27 non-ICU and 21 ICU) with positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were analyzed (mean age, 66 years, [range, 33–88 years]; 67% males). There were no differences in age or sex among groups. Initial symptoms included fever (100%), coughing (85%), dyspnea (76%), diarrhea (42%) and asthenia (21%). ICU patients had a higher prevalence of dyspnea compared to non-ICU patients (95% vs. 61%, p = 0.022). ICU-patients had lymphopenia as well as hypoalbuminemia. Lactate dehydrogenase (LDH), C-reactive protein (CRP), and procalcitonin were significantly higher in ICU patients compared to non-ICU (p < 0.001). Lower albumin levels were associated with poor prognosis measured as longer hospital length (r = −0.472, p < 0.001) and mortality (r = −0.424, p = 0.003). As of 28 April 2020, 10 patients (8 ICU and 2 non-ICU) have died (21% mortality), and while 100% of the non-ICU patients have been discharged, 33% of the ICU patients still remained hospitalized (5 in ICU and 2 had been transferred to ward). Critically ill patients with COVID-19 present lymphopenia, hypoalbuminemia and high levels of inflammation.

Fecha

2020

Materia

inflammation, covid-19, albumin

Identificador

10.3390/microorganisms8081106

Fuente

Epidemiology and Health

Editor

Korean Society of Epidemiology

Cobertura

Biology (General)

Archivos

https://socictopen.socict.org/files/to_import/pdfs/cd10aafbc14007b3fa3b9b7917715555.pdf

Colección

Citación

Roberto de la Rica, Marcio Borges, Maria Aranda, Alberto del Castillo, Antonia Socias, Antoni Payeras, Gemma Rialp, Lorenzo Socias, Lluis Masmiquel, Marta Gonzalez-Freire, “Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study,” SOCICT Open, consulta 18 de abril de 2026, https://www.socictopen.socict.org/items/show/7497.

Formatos de Salida

Position: 12068 (23 views)